Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

MSL Talk

Activity to Impact: How MSLs Prove Value

Feb 10, 202634 minVideo
ShareXLinkedInFacebookWhatsAppEmail

Tom Caravela and Dee Dee Gwinn explore the evolving value of medical affairs, starting with the significance of wearing red for heart awareness. They discuss the challenges and misconceptions surrounding the value of Medical Science Liaisons, emphasizing the importance of impact over mere activity. The conversation highlights MSL contributions from internal perspectives and strategies for demonstrating value to external stakeholders, illustrated by a case study of high-value MSL collaboration. Leadership advocacy and practical advice for MSLs on showcasing their value are covered. The episode concludes with a focus on maintaining a value-driven mindset, strategic actions, and expressions of gratitude to the audience.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show.

0:00Hey, guys. Welcome to the podcast. Really excited because I have a dear friend that I've known for a long time that's joining us. Didi Gwynn, welcome to the podcast. Thank you, Tom, and thank you so much for inviting me to be part of this podcast. It's an honor to be here, and and I'm looking forward to it. And, guys, so Didi and I, like I said, we know each other a long time, and I just think the world of her, and I couldn't wait to share her with you. And we were kinda trying to come up with some ideas for topics, and we we landed on something

0:35that I know you guys always love to hear about, and that is and it's called from activity to impact at from activity to impact, how MSLs prove their value. We hear the value word being thrown around so much that I think it was time to have another episode about it. But before we do that, Didi, why don't you introduction? Yeah. Sure thing. So Didi Gwen, obviously, I, like most people, in the medical affairs field medical affairs

1:08position, started out as a clinical pharmacist and was at Duke for a few years. And then from there, moved to Sanofi where I worked with Lovenox, Plavix. I was in the cardiology space, the thrombosis space, and was an awesome MSL. Yeah. You were. And then, was eventually promoted, to regional, director. And then, some changes went about, and I joined Biogen where I was at for the past six years,

1:43managing the West field team, in multiple sclerosis and immunology. Probably most of you all are picking up on the southern accent. I spent most of my life on the on the East Coast, and so moving out to the West was was a big life change, not only for work, but also personally. But I live in beautiful Park City, and I would ask that you all please send us your snow from the East. We're having the worst winter ever.

2:15But, yeah, that's that's, me in a nutshell. Yeah. And so if you guys are listening and not watching this, you'll you'll, you'll miss the fact that Didi's wearing red today. So why why what's the significance of the red today? Yeah. So, February is heart awareness month, and so, we always have a wear wear red day for women because we're trying to bring awareness of the cardiovascular risk in women and and also

2:48helping them to learn that it's important to know your numbers, your cholesterol, your high blood pressure. You know, heart disease can present differently within women. And so making them aware of this is is very important, in in terms of achieving goals during heart awareness month. And, I wanna do a shout out to Kimmy Vesta who reminded me that it was wear red day on LinkedIn. And so yeah. So so this is, this is how I picked up my attire today.

3:19I love it. Awesome. And and oh, one other thing, guys. Before I forget, I knew there's a couple of things we needed to cover before we started talking, but we are starting to get excited about Fierce Pharma Engage is coming up really soon. It's April 22 to the twenty fourth, and that's in San Diego. This used to be Mass West. So for any of you guys that were big fans of the medical affairs strategic summit west, this is now called Fierce Pharma Engage, and it's a larger event that brings together cross

3:53functional teams. So it's not just medical affairs. It's also, pharma marketing, PR and communications, and business development and licensing, BD and L. So there's there's four cross functional groups. It's in sunny San Diego. It's a great event. They had their first one last year. It was awesome. They're doing it again this year. And you can check it out at Fierce Pharma Engage. Just type that in. Fierce Pharma Engage twenty '26 on the Internet, and then, and definitely register.

4:26I will definitely be there, and I hope to see you guys. So, Didi, let's jump into this. So, we we hear the word value a lot. You go to any medical affairs conference, there's gonna they're gonna be talking about value. But the question I have for you and the place I wanna start is, like, what does that mean today, right now? Yeah. Exactly. And and thank you for allowing me to come on and talk about a topic that I am very passionate about.

4:58If I get on my soapbox a few times, just, you feel free to not to nudge me up not nod, nudge me off. But when I think about value today in the context of medical affairs, I think of the impact they're having on clinical behavior that improve patient outcomes. And, you know, historically, the role has about has been about counting, you know, with we see so many engagements.

5:28We do so many presentations. We engage with so many k KOLs. That's gonna have positive outcomes. And, you know, we started in that metrics path because I really feel like that we allowed our internal stakeholders, you know, be it the way commercial measures things, to kinda tell us how to to tell our story. But you and I both know that it's so much more than what we do.

5:59So, essentially, value today is taking all the stuff that that our teams do, the clinical trial support, the education, the relationships that they create with with KOLs. And instead of instead of, you know, counting those, taking it a step further and say, okay. This team's involvement in this clinical trial, allowed enrollment to to end earlier. In fact, that did happen earlier in my career as as our team's enrollment allowed a product

6:35to be FDA submitted to the FDA a year earlier than planned. And you I mean, that's just incredible impact and allowed us to be first in market of a new class of medications. It's, you know, the scientific exchange and and, you know, education we do that's changing clinical behavior. And then lastly, it's the relationships that we create, those peer to peer relationships that we create where KOLs become our advocates. It's not just Didi out there talking about drug x is better than drug y, and this is, you know,

7:09the context and differentiation of the products. They are the ones that are out there carrying the message, of of our product and where the product should be used within the management of of the specific, disease state. So looking at I mean, that that all sounds reasonable, and it it sounds fair. And I think everybody would would agree with that. But so why is it that so many MSLs seem to struggle with this piece and maybe have trouble

7:41articulating and understanding the nuances to that messaging? What's where's where's the issue there? Yeah. Well, I I think when you think about the MSL role and where many of the individuals started their early careers, you know, we're and I, myself, suffer from from this as as well, is we're just we're in you know, we're usually clinicians. We're in these jobs where we just sort of roll up our sleeves.

8:13We get the job done. We do you know, we take care of our patients and and what have you. And so then we transition into these roles where not everybody is seeing what we are doing from day to day. You know, we're just out there again rolling out our up our sleeves, and doing the work. And there's just this assumption that they that we have is that the internal stakeholders will will get it. But I also think that it's largely because the role initially has was pigeonholed into

8:49thinking more is better. You know, the the higher, engagements I have, the more congress engagements I have, then I'm I'm doing a better job. And this is something that we as leaders have struggled with because more always doesn't equal better. But I do think that and you're gonna hear me say this throughout the podcast, and this is one of my take home messages. We medical, we have to own our narrative.

9:20It's it's time for us to stop allowing other functions to to own what our narrative is. So the let me I wanna the more is better trap. Do you think that the MSLs may think more more is better, because of, you know, maybe internal pressure metrics or whether or not metrics are defined well enough, but just internal

9:52pressures or their ability to maybe convince themselves that if they do more, they're actually doing better. Yeah. I I think that there sometimes is a mistake in that looking that maybe a MSL has higher numbers. The all that means, Tom, is they're busier. Yeah. Okay? And, a leader, you know, once gave me a great phrase, just work the territory. Everything will fall in into place.

10:24And so if you're you're focusing on, you know, closing the educational gaps, creating the relationships, giving the medical support that is needed, and executing the medical strategy, everything will take care of its place. And I will say that historically, the best MSL the MSLs have brought the the the most value weren't my ones with the the highest numbers. But there are pressures internally, because even though upper leadership says we need you

11:00know, so what you had x number of interactions? So what? I mean, you know, executive leadership is starting to ask those questions. It still goes back still circles back around to the numbers, the activity, the reach and frequency model. And so, you know, as a leader, some I have to stop myself whenever I'm coaching my team, working with my team to not focus on the numbers. Yeah. You know, when we have a one on one, I don't need to throw up the Power BI slide.

11:31This is this is where you are. And then, also, when I'm telling their narrative or being their advocate, you know, focusing on the impact. So we all own it. It's not just the the MSLs, but it's it's the leaders as as well to help change that that mindset. Yeah. I love that focus on the impact. That kinda changes everything when when you put that put it into that perspective. I do think, though, that m s some MSLs unintentionally undervalue themselves, both

12:10internally and externally. Do you agree with that? Have you is that something you've seen? Yeah. Yeah. I mean, they, you know, it's it's historically, you know, you I I've had many MSLs. I you know, I've probably only had one, maybe two MSLs through my, you know, leadership career, that of over ten years that they they knew how to sell themselves.

12:43Yep. And, you know, one of them, interestingly enough, was, was a sales professional. They were a PhD by trainee. Entered cell was a sales professional to but trans transitioned over to the MSL role. That was their actual career goal. They were they were really, really, great. And, you know, again, we've we have to they have to own the narrative.

13:14And and I'll give you an example of of a real world example of where this happened is, in my past leadership roles, I had a field medical personnel that identified a problem within their territory. They also, you know, did basically, they did all the work to resolve the problem, which allowed patients to have more in, access to to the product.

13:45And so all MSL were. It was the internal stakeholders. No one else did this. Well, the MSL communicated to their stakeholder, okay. This is you know, I just wanna update you that this has been done. So about a week later, the, this notification went out, and, essentially, the internal stakeholder was taking credit for what had happened. And so my team team member called me mad.

14:17Like, I did everything. They weren't even aware. They didn't even know if no. I'm like I said, but you communicated this to me, like, a week ago. Why is it that you didn't send out that communication? And so it goes back to this owning the narrative part, telling telling our story. And they said, well, this isn't the way the the usual procedure that we communicate these this within the organization. I said, who made that rule? And and so, again, I think that MSLs, you know, they're shy by nature.

14:52You is be proud of what you've done. I mean, that particular example, you know, was an incredible accomplishment, and and the impact that it had on allowing patients to have more access to the product was wasn't so don't be afraid to tell your tell your story. You all all MSLs will always tell you, I do this for the patients. Well, if you can maybe think of that mindset of, you know, being afraid to to toot your

15:23horn. By the way, you know, you're just talk about the patients that you you know, put that at the focus of of what you improved through your work. You know, it's interesting that you bring that this topic up of, you know, kind of being your own advocate and speaking up and being the one that, comes forth with some of this stuff. We just I just did an episode, two weeks ago called Shameless Self Promotion with Amy Everett, who was awesome.

15:54It's a great episode. People are commenting still commenting about it because it's that's not something that's talked about. We've I've never actually even had it on my podcast, and it's interesting that we're talking about it again now because it's so important, and we had a whole episode about it. So so shameless plug for my shameless self promotion episode. Go check it out. Oh, I was glad to see that. Honestly, I was glad to see that topic. I said this is what we need as medical.

16:25So another plug for everyone to go list go back to listening to that podcast. Amy. Yeah. Like, it came from her. I was like, yeah. We're definitely doing that. That sounds awesome. Like, I I love that concept. So we're talking here about so high value MSL contributions. Mhmm. What would you say internal departments so the different internal departments like medical commercial leadership teams.

16:56What do they actually see as high value MSL contributions, Would you say? Well, I will say that this is an area that there is still a disconnect. You know, they say, okay. We want to see impact, but maybe they're not as patient as they need to be to see that impact occur. You know? We've always have our quarterly reports.

17:27And, you know, as we both know that the work that our teams do in the field takes time. It's and to draw an example from our commercial colleagues, you know, they do their calls and usually meet you know, within a week or two, they can see prescription volume or some to their their labor per se. But with with change in clinical behavior, impact on patients, it it takes time to see

17:58those changes. And so when you are changing from an act activity to impact message, you you have to sort of marry those into the like, you know, the activities, you know, are showing from quarter to quarter. They're they're working. Okay? And so those are sort of the leading indicators. So we believe that if you do x number of this, it's gonna do that. But the lagging indicators, which are essentially the impact, it may not change for

18:35twelve months. If you're if you're measuring your impact, which is a common way to do it, is mindset shifts within a HCP's beliefs. So it may not change until the end end of the year. And so for, you know, executive leadership that's wanting to see performance now now now, it's you're not you're not gonna see it as as quickly. The other thing is I lost my train of thought because my dog started started barking.

19:13But, is when we're coming up with these these lagging indicators that are measuring our impact, they may not be easy data to get, and we have to think outside the box. So, you know, it may be social listening. It may be pulling claims database and seeing, for example, in a rare disease environment, the MSL education about a certain rare disease, maybe their impact is increasing genetic testing o over a period of time.

19:44You're not gonna see that over overnight. So I think that, you know, at the end of the day, our goals are shared with all of our internal stakeholders and cross functional partners and that we wanna bring our solutions to patients. But, again, we need to own the narrative of what that story is and, you know, getting the buy in from our from our partners as to how that story needs to be told so we're not reverting back to the same x number, this this and this.

20:18Got you. Yeah. And now when we shift to external stakeholders, what, what would you say meaningful value looks like to them beyond data delivery and slide decks? Mhmm. Yeah. I you know, obviously, internal, external stakeholders, they have different needs, and and and so they're gonna define value in different different ways is you know, I think

20:54that to earn the relationship with an HCP and the trust is you have to get a kind of what's in it for me kind of mentality. And so, you know, they want to be the the knowledge. You know? They wanna be on the cutting edge of all the all the data. So making sure that this is, you know, that they're they're getting regular regular updates.

21:24Also, it's, you know, it's also helping them gain exposure, especially whenever you're working with early career, k KOL. So those are how the trusting relationships get created. And then when you see them kinda shifting, it's when the MSL is seen as a peer or a partner to them, as a thought partner. And I've had, you know, many cases when it's actually the KOL that's reaching out to to them

21:59and saying, hey. Did you see this data that was presented? Like, hey. What do you what do you think think about that? And so to me, that's whenever I know that, you know, the MSL is bringing value. The KOLs are having the moment, and they're out there be being advocates for our products, and and the patients that that we serve. Yeah. Do you, you have any good stories? Like, do you have any good examples of how maybe there was an MSL that was really good at,

22:33you know, this this, this demonstrating value and what made what made that person stand out. Yeah. Well, I got lots of stories, Tom. I know you do. That's why I asked. Yeah. I've been doing this for for several years. I have many, many examples and had had the the, pleasure of leading many MSLs who, you know, motivated me and inspired me because of the dedication, that they they had, to the patients

23:07and the HCPs which they serve. But I think that one of the strongest examples that I've seen most recently is a MSL, you know, was trusted, had met all those partner, peer, and and all that, that partnered with the KOL to create a to do a study. And the study eventually became not just the investigator initiated study, but it came one

23:39in which the corporation, wanted wanted to sponsor. And so what the problem that they were trying to solve is that the current administration of the product led to an increase of a very rare but serious side effect. Okay? And so the MSL partnered with this KOL and created you know, their hypothesis was was positive and that it did, the that using this drug in this different way from the label

24:18improved the safety and then decreased the risk of that serious side effect that patients could see. And, it's just incredible because it that is the perfect example of this changed clinical behavior that improved patient outcomes. That MSL didn't get there overnight. They had to become a trusted partner, both internally and externally.

24:48They had to have the business acumen to understand of, like, what this meant to the business. And then they had to just they had to be a strong collaborator, because there was a lot of moving pieces both externally and, and internally to to make this make this happen. So so, yeah, this is, you know, one of the best examples of what we do and how we can really improve patients' lives by changing the way that, clinical behavior is done.

25:19And so the story you just told, just curious. Like, did did the MSL communicate this well and advocate for themself, and bring that story back to you, or did you just happen to like, I'm curious as to what was brought back to you and how you learned of this. Yeah. No. The so, I was very shy about this, but because there were so many moving parts, it you know,

25:50all levels of the organization was was aware of it. Yeah. And and so but no. And they this particular MSL still does not advocate for themselves very well. But see, that's what that's what our jobs are. I mean, when when people ask me as a field director, what do you think your number one job is? And I and I said, well, I said, actually, I think I have two. I think one is that I remove barriers for people so they can do their job. And number two, I tell their story for them internally.

26:22I advocate for them. I said, your job is to create the story. My job is to tell it for you. That's why you're such an amazing leader. Thank you. Thank you. But I think that part of the reason for that is because MSLs are so used to just reporting activity versus sharing impact versus demonstrating value. So let's talk about that. How does an MSL get better at not just reporting activity, but also incorporating and

26:56including how they're demonstrating value? Yeah. So, again, I think this is something that we, as leaders, really own, is that the you know, reporting the activity is never never gonna go away. Mhmm. And, you know, we have to learn or create systems where the impact can be more readily communicated.

27:27Now I will tell you as a disclaimer, as, you know, you do, try to move to more of an impact reporting model and say, for example, one of your impact measures is change in physician mindset over a time period period of time, you do add to the to the burden, you know, of the MSL in terms of their data recording. But you you have to remind them as the why behind that. You know? You've you keep telling me that, you know, you it's more it's beyond the metric.

28:04You, this is how we're transitioning to be able to tell your impact. Also, you know, I think we, as managers too, is not I I always say it's dangerous to interpret a metric in isolation. And, you know, that's why I always cringe when dashboards get sent up, you know, for, for leaders to view, you know, without the story the story being told.

28:34And so, you know, we as leaders, you know, I'm not just looking at how many times you did something. It's, you know, understanding the story, you know, behind that. What the what did that lead lead to? And, you know, I think as we work with our internal stakeholders, we've gotta shift that narrative as well. You know, whenever you know, my my internal partner is asking me, well, what's your team doing? What what have they accomplished?

29:05Well, you know, a lot of times they wanna know how many times did they show this new publication to these people. And I'm like, well, no. Let me let me tell you about, you know, the the tweet that doctor so and so put out there that, you know, basically summarize this data and how this data could be could be used. So, you know, owning my narrative as I talk to, you know, manage up and manage laterally with my internal stakeholders.

29:37So let's just say I'm an MSL listening today, and I I wanted to do something to improve the value that I show, like, in the next ninety days. Yeah. What would you tell that person? So first of all, you would hope that the, MSL is is use is strategic taking a strategic planning approach to the territory, which that is something that we could have a discussion

30:11in the part two. Yeah. That's a but, have you know, based on what the medical affairs strategy is is identify identify a problem that that or educational gap in your territory. So, you know, a KOL, an institution, or whatever, and plan like, okay. These are the solutions that I think can help close that educational gap within within that

30:41area. And then you need to then they, you know, should sit back and see the evolution. Like, when they go back in and they visit that KOL, has the conversation changed? Do they feel like they're in a true dialogue versus trying to explain the data? Has their insights gotten deeper, or are they sitting at a con a congress or a local, educational program, and their, KOL is basically parody words that they told them

31:16about the the information that they shared? So that would be, you know, be intentional about it, about your your you know, what you're trying to do in your territory. Manage your territory. Don't let your territory manage you. And then the last thing I would tell them to do is tell somebody. Tell their tell their cross functional partners. Tell their manager, you know, as to, hey. I did this. This is the impact that that I that these three activities had. Yeah.

31:48And, you know, I started by saying that you hear the word value get thrown around so much, but I also think that sometimes MSLs just get they get a little more caught up in the day to day activities. So do you think that it's a mindset? Do you think there's a mindset shift that needs to happen in MSLs to be more value focused? Yeah. I I do. And I think that, number one, it does begin with being strategic with your territory, and I

32:22get it. I mean, stuff happens. You get requests here. This happens. You know, get a request from that KOL. But it's in the the day, you know, know your territory. Be strategic about your actions. And then whenever you you you are, you know, doing your reflection, your data recording of that, is think next to, you know, what was what was my impact, on that? And then, like I said, I'm gonna say this over and over again, own that narrative.

32:57And and there's a saying, if you don't tell your story, someone else is gonna tell that story for you. And I think that that perfect example that I shared earlier about the MSL doing all the work, but the cross functional partner taking the credit for it, that's a someone else will tell their version of the story if you don't tell yours. I think that actually came up in our that episode with Amy about the shameless self promotion, that exact quote. So clearly, we're meant to hear that, and we're meant to pay attention to that.

33:29So I'll tell you, Didi, you're awesome. I knew this was gonna be awesome. I couldn't wait, and that was a jeez. That was a really quick thirty minutes. So thank you for coming on. Yeah. Thank you so much, Tom. I really appreciate it. Awesome. And as always, guys, thank you for joining us. Thank you for all your support of the show. I know there's so many people that are sharing it, and they're commenting. And I do I really do appreciate it. You guys are the best. I love you all, and I'll see you guys next time.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. The Wrong Voices: How Bad Mentors Can Ruin Your Career

    Nov 17, 202628 minVideo

    What qualifies someone to influence your future? Tom Caravela explains why career guidance should be filtered through relevant experience, current knowledge, credibility, and objectivity. He examines the risks of...

    Listen to the audio

    Credit the people on this episode

  2. Hidden Secret to Career Happiness and Longevity

    Nov 3, 202635 minVideo

    What turns an industry contact into a long-term ally? In this episode, Tom Caravela and Ed Doherty look beyond transactional networking to the genuine friendships that can shape a career in medical affairs. They discuss...

    Listen to the audio

    Credit the people on this episode

  3. How to AI-Proof Your Career: The 4 Pillars of Career Success

    Oct 20, 202623 minVideo

    Becoming undeniable is Tom Caravela’s answer to building career security in the age of AI. He breaks down four pillars you can control: skills, experience, relationships, and brand. Tom explains how continuous learning...

    Listen to the audio

    Credit the people on this episode

  4. How Medical Affairs Influences Decisions that Matter

    Oct 13, 202638 minVideo

    What happens after an MSL submits an insight? In this episode, Tom Caravela and Cameron Tew examine how field observations create value only when organizations decide what to do next. They discuss shared definitions,...

    Listen to the audio

    Credit the people on this episode

  5. Stop Being Your Own Worst Enemy

    Sep 29, 202619 minVideo

    In this episode, Tom Caravela discusses common mindset traps that can hold Medical Science Liaisons and aspiring MSLs back. He covers how to move past worst-case thinking, overanalysis, concern about others’ opinions,...

    Listen to the audio

    Credit the people on this episode